Physician
Saints Medical Group, LLC
Saints Medical Group, LLC was paid $14.52M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoSAINTS MEDICAL GROUP, LLC
SHAWNEE, OK 74804
SHAWNEE, OK 74804
33aNPI1881648285assigned 05/20/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$14.52M
24GClaims281,340
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Oklahoma
Rank by total paid#1 of 7
Median peer was paid$203K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MANUEL, SHASTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,586 | $2.43M | |
| 2019 | 45,333 | $2.55M | |
| 2020 | 40,369 | $2.13M | |
| 2021 | 42,100 | $2.03M | |
| 2022 | 30,942 | $1.61M | |
| 2023 | 40,240 | $2.01M | |
| 2024incomplete | 34,770 | $1.76M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 65,626 | 62,846 | $5.43M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 40,666 | 38,478 | $2.50M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.3% | 12,127 | 11,505 | $1.05M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.0% | 7,822 | 7,819 | $726K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5.0% | 15,816 | 5,030 | $719K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.9% | 9,150 | 3,000 | $572K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 3.8% | 329 | 329 | $555K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.2% | 13,368 | 13,224 | $462K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.9% | 23,842 | 23,667 | $427K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.7% | 7,931 | 2,683 | $246K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 8,465 | 8,283 | $235K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 3,381 | 3,349 | $225K |
120 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 2,608 | $204K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 13,170 | $187K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 1,477 | $158K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,315 | $122K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 872 | $62K |
| 99205 | Prolong outpt/office vis | <1% | 323 | $45K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,666 | $43K |
| 90474 | <1% | 2,088 | $37K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 212 | $35K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,797 | $32K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,562 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 605 | $27K |
| 97533 | <1% | 458 | $25K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 306 | $25K |
| 99460 | <1% | 282 | $24K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 222 | $23K |
| 90962 | <1% | 729 | $22K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 326 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,539 | $19K |
| 90715 | <1% | 624 | $18K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 945 | $17K |
| 99223 | Prolong inpt eval add15 m | <1% | 203 | $17K |
| 0001A | <1% | 292 | $12K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 282 | $12K |
| 0002A | <1% | 264 | $11K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 91 | $8K |
| 87807 | <1% | 581 | $7K | |
| 99188 | <1% | 529 | $6K | |
| 74019 | <1% | 252 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 52 | $5K |
| 0071A | <1% | 130 | $5K | |
| 90686 | <1% | 4,078 | $5K | |
| 92567 | <1% | 407 | $5K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 186 | $4K |
| 95251 | <1% | 172 | $4K | |
| 0012A | <1% | 107 | $4K | |
| 97162 | <1% | 54 | $4K | |
| 94060 | <1% | 647 | $4K | |
| 0072A | <1% | 98 | $4K | |
| 76801 | <1% | 62 | $3K | |
| 96161 | <1% | 669 | $3K | |
| 0011A | <1% | 117 | $3K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 39 | $3K |
| 90961 | <1% | 55 | $3K | |
| 71271 | <1% | 39 | $3K | |
| 97167 | <1% | 36 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 344 | $3K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 12 | $3K |
| 95115 | <1% | 453 | $2K | |
| 96127 | <1% | 584 | $2K | |
| 92523 | <1% | 12 | $2K | |
| 96381 | <1% | 132 | $2K | |
| 97165 | <1% | 25 | $2K | |
| 20610 | <1% | 60 | $2K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 87 | $2K |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 12 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 96 | $2K |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 63 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 182 | $2K |
| 93000 | <1% | 162 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 237 | $1K |
| 93971 | <1% | 92 | $1K | |
| 72141 | <1% | 12 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 118 | $1K |
| 92557 | <1% | 39 | $1K | |
| 71250 | <1% | 24 | $1K | |
| 73110 | <1% | 46 | $1K | |
| 80061 | Lipid panel | <1% | 96 | $1K |
| 81003 | <1% | 447 | $950.10 | |
| 74018 | <1% | 51 | $879.12 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 60 | $863.50 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 67 | $850.18 |
| 76536 | <1% | 12 | $835.52 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 27 | $734.81 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $557.67 |
| 0004A | <1% | 13 | $520.00 | |
| 92579 | <1% | 13 | $493.09 | |
| 90656 | <1% | 548 | $460.62 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $443.88 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $375.16 |
| 72100 | <1% | 14 | $319.20 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 153 | $312.13 |
| 73562 | <1% | 12 | $311.56 | |
| 90677 | <1% | 1,211 | $280.05 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 395 | $272.98 |
| 90688 | <1% | 84 | $249.76 | |
| 93016 | <1% | 14 | $248.63 | |
| 92555 | <1% | 12 | $233.64 | |
| 73630 | <1% | 12 | $222.14 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 24 | $183.31 |
| 93018 | <1% | 14 | $164.78 | |
| 99442 | <1% | 12 | $157.66 | |
| 80069 | <1% | 17 | $150.60 | |
| 93880 | <1% | 12 | $139.21 | |
| 90734 | <1% | 124 | $125.50 | |
| 84439 | <1% | 14 | $112.28 | |
| 92551 | <1% | 12 | $111.84 | |
| 81025 | <1% | 13 | $85.97 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 41 | $77.09 |
| 99173 | <1% | 14 | $35.28 | |
| 96160 | <1% | 119 | $4.52 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 13 | $4.16 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 12 | $1.14 |
| 90681 | <1% | 2,016 | $0.43 | |
| 90633 | <1% | 1,471 | $0.13 | |
| 90381 | <1% | 124 | $0.12 | |
| 90670 | <1% | 3,826 | $0.01 | |
| 90380 | <1% | 14 | $0.01 | |
| 90707 | 0% | 242 | $0.00 | |
| 90710 | 0% | 150 | $0.00 | |
| 90700 | 0% | 167 | $0.00 | |
| 90685 | 0% | 13 | $0.00 | |
| 91308 | 0% | 55 | $0.00 | |
| 90648 | 0% | 29 | $0.00 | |
| 90723 | 0% | 3,656 | $0.00 | |
| 90647 | 0% | 3,510 | $0.00 | |
| 90716 | 0% | 243 | $0.00 | |
| 90696 | 0% | 93 | $0.00 | |
| 90651 | 0% | 98 | $0.00 | |
| 90680 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANUEL, SHASTA (VICE PRESIDENT - FINANCE)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Oklahoma, INC. | Oklahoma City, OK | $46.86M |
| ST Anthony Shawnee Hospital INC | Shawnee, OK | $23.00M |
| Saint Medical Group, LLC | Shawnee, OK | $4.51M |
| SSM Regional Health Services | Jefferson City, MO | $2.49M |
| Saints Medical Group, LLC | Shawnee, OK | $1.32M |
| SSM Regional Health Services | Jefferson City, MO | $1.26M |
| SSM Health Care of Oklahoma, INC. | Oklahoma City, OK | $856K |
| SSM Regional Health Services | Jefferson City, MO | $842K |
| SSM Regional Health Services | Jefferson City, MO | $398K |
| SSM Regional Health Services | Belle, MO | $388K |
| SSM Regional Health Services | Tipton, MO | $304K |
| SSM Health Care of Oklahoma, INC | Oklahoma City, OK | $269K |
| Saint Medical Group, LLC | Tecumseh, OK | $246K |
| SSM Regional Health Services | Jefferson City, MO | $239K |
| Saint Medical Group, LLC | Chandler, OK | $194K |
| SSM Regional Health Services | Jefferson City, MO | $191K |
| Saints Medical Group, LLC | Okemah, OK | $165K |
| SSM Regional Health Services | Jefferson City, MO | $149K |
| Saints Medical Group, LLC | Oklahoma City, OK | $84K |
| SSM Regional Health Services | Jefferson City, MO | $61K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.